SCHEMBL584528

SCHEMBL584528

O=C(O)[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1765577 1.00 OR51E2 (1.00)
SCHEMBL29597490 1.00
Water SCHEMBL21753470 1.00
SCHEMBL38462 1.00
SCHEMBL2905876 1.00
Water SCHEMBL10757023 1.00
SCHEMBL29278852 1.00 OR51E2 (1.00)
SCHEMBL9651911 0.97
SCHEMBL10789759 0.97
SCHEMBL9251246 0.97 OR51E2 (0.93)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4679085-A1 BIOMARKER AND USE THEREOF MEIJI CO., LTD (JP) 2026-01-14 EP claimed
EP-4594520-A2 COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS Sixfold Bioscience Ltd. (GB) 2025-08-06 EP claimed
EP-4547641-A1 LIQUID-PHASE PROCESS FOR THE PRODUCTION OF ACRYLIC ACID ESTERS FROM GLYCERIC ACID Kemijski Institut (SI) 2025-05-07 EP claimed
US-20250108021-A1 METHOD FOR ENHANCING ENERGY PRODUCTION AND METABOLISM IN CELLS REPLICON HEALTH OY (FI) 2025-04-03 US claimed
WO-2025061711-A1 USE OF GLUCOSYLGLYCERATE PHOSPHORYLASES WITH HIGH ACTIVITY ON SUCROSE UNIVERSITEIT GENT (BE) 2025-03-27 WO claimed
WO-2025021274-A1 Liquid-phase process for the production of acrylic acid esters from glyceric acid KEMIJSKI INSTITUT (SI) 2025-01-30 WO claimed
WO-2024215637-A1 DIAGNOSTIC SCREENING BIOMARKER FOR STONEFORMERS THE UAB RESEARCH FOUNDATION (US) 2024-10-17 WO claimed
US-20240309417-A1 Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals GONZALEZ RAMON (US) 2024-09-19 US claimed
WO-2024190666-A1 BIOMARKER AND USE THEREOF 株式会社明治 2024-09-19 WO claimed
US-12083084-B2 Method for enhancing energy production and metabolism in cells REPLICON HEALTH OY (FI) 2024-09-10 US claimed
EP-4141122-A2 CARBON-NEUTRAL AND CARBON-POSITIVE PHOTORESPIRATION BYPASS ROUTES SUPPORTING HIGHER PHOTOSYNTHETIC RATE AND YIELD Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-03-01 EP claimed
WO-2023015285-A1 MICROORGANISMS AND METHODS FOR IMPROVED BIOLOGICAL PRODUCTION OF ETHYLENE GLYCOL LANZATECH, INC. (US) 2023-02-09 WO claimed
US-11555209-B2 Microorganisms and methods for the biological production of ethylene glycol LANZATECH, INC. (US) 2023-01-17 US claimed
US-20220348897-A1 GENETICALLY OPTIMISED MICROORGANISM FOR PRODUCING MOLECULES OF INTEREST EPPEN EUROPE (FR) 2022-11-03 US claimed
US-11357746-B2 Method for enhancing energy production and metabolism in cells REPLICON HEALTH OY (FI) 2022-06-14 US claimed
CN-107299072-A Engineering bacterium and application thereof 江南大学 2017-10-27 CN claimed
EP-1854792-B1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-12-26 EP claimed
US-20090030195-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-01-29 US claimed
CN-101160303-A 1- (2H) -isoquinolone derivatives CHUGAI PHARMACEUTICAL CO LTD (JP) 2008-04-09 CN claimed
EP-1854792-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-11-14 EP claimed